The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Allatsea if you followed the recent news, gsk are making great strides in the vaccine front on covid. Late in the party , but long term it will serve well.
Does anyone know what the contracts of these are is it sold at cost for first full jab then sold at profit?
I wouldnt be surprised if Elliott did they dont stick around and want to make quick gains, questions still not be answered why Glaxo had fallen behind again in my previous post this started years ago and not recently, Astra has outperformed Glaxo.
What proves about the pharma business the CEO's are pretty useless, i wish they were paid less as they dont really add much value (Ok can be said for most companies) and more scientists are recruited and we pay for top talent. EW is not top talent over rated sales woman.
The split is assuming the sum of the parts will be more valuable and synergies in the consumer side will be able to service the higher levels of debt so the pharma business can invest more and build on the pipeline, which it has been weak about for many years. I am hoping the strategic tie ups will pay off in years to come.
Not a fan of the CEO, but she should be given the chance to run her strategy, but she cant run the pharma business she is out of her depth there, better off on the consumer side. She is not to blame for the pipeline this started many years ago.
Good news on the covid treatments, but not sure if they promised to sell at cost or for a small mark up. We have a number and they are looking positive.
F29 agree, i really do not know if a deal will be concluded now by the deadline and if it does, it will be very different to what i was expecting a few months ago, we have rothschilds and it would be interesting what there take is on this, as we need to
The whole green transition really works in our favour, I want the board to really get the best deal for us, if that means we dont do a bad deal then i would agree, it is just not once have we had a communicated offer that it has either been too low and instantly rejected or they are proving up more.
I rather we see more RNS on the plant and CASA finalising and then a plan for Botswana, Zambia will come along i am not hoping that RNS will land as I dont think it will now.
Shadow, FACT is Anglo have signed an EA and Rothschilds are on board, people are not expecting a deal is certain but the facts are we are certainly seeing discussions behind the scenes and the price can range anywhere, but certainly, i dont think these guys will contest anything valuing us at less than 10-20p here as they are confident.
Also Look up the word called Exclusivity, it would be disrespectful to discuss to others when we have given anglo an opp and no, names can not be mentioned as ARCM do not have to give that information out as nothing formal yet.
There is a route to cash flow in next 18 months and minimises dilution which often happens, the last dilution was at 6.4p which was a good price and the reasons for it have been given.
So deramp as much as you like, doesnt impact my investment here what so ever.
Placing doesn’t need to happen, they should debt finance if they can’t get a deal done.
A lot of backs will do that if the assets are good and can be secured against the debt.
Too many excuses of covid delaying this, has anyone asked for a open investor relations call.
Longfellow/Marco
I’m hoping this is my first multi bagger. I missed out on arb, it’s too volatile for me missed that at 5p I bought higher and doubled my money but lost some of that being greedy.
What else are you looking at?
We are in no rush to sell longfell, I want to see and hear more about the plant at Cheyza east. Anything else is a bonus for me, if news drops.
I am invetsed here and not looking to trade, i will hold if pull back as we believe we have a lot of copper and selling out of frustration has already kicked me badly on GGP when i invested initially in 2013 and sold out around 2017 ( i doubled my money, missed out on 120 bagger lol) If i held out for 1-2 more years i would be laughing, i had £5k invested around 0.3p level.
Well it could be of the Zambia assets and could split the rest into the shell company going forward.
I thought we might, but this board are confident they own a lot of copper and any price now would really represent its true value, unless AA offer us a deal we really could not pass on.
I don't think a deal will be done by the EA deadline now, i think it will be extended. If we get a deal before then I will be surprised, I just dont think we will get the exploration drilling assays back on time.
Hi Tom,
Offering shares from AA would be a good idea but only would expect that from a full takeover and think people are gravitating away from that idea.
I like what AA are doing as they are looking to become more efficient and reduce their cost base to c $2.5 - $4bn a year from 2022. so buying us and developing would be a drop in the ocean.
Do not think they are concerned with employees, they are looking at maximising their own returns, look at her pay packet over the last few years. That is what troubles me the SP has under performed but yet her bank balance has done really well, also not shy to be a member of other companies boards.
Think she should be allowed to see through her strategy as this is not entirely her fault, started years ago and she has not been able to fully execute it yet. But that aside she has been with the company more than 10 years, largely running the Consumer Healthcare , she is not the right person to run the vaccine and pharma business that is apparent.
The costly acquisitions has been a catch up due to her predecessors not matching others on research and getting rid of the oncology business.
Don't think the dividend needs to be cut by much, but we really need to see the pipeline grow. Good recent new on the Covid vaccines news, we can be a big player in the years to come, blessing in disguise with the issues dogging Astra now with Europe. Who have done an an immaculate job getting something out there by the way.
Wish the board ask shareholders if an extension is approved. If AA can’t offer a tempting deal and doesn’t mean they offer a billion, but both parties are incentivised after having 12 months of the first opportunity to bid. I rather we had an open tender and see who comes up with the best value for ARCM.
I rather we have no deal now than a bad deal and could get a lot of value through more drilling or opening up to others.
This board have made it clear we don’t need a deal at a bad price.
Deal or no deal, we know we have copper deposits just don’t know how much and others are interested.
NVS has dealt with the licence issues , if he is lying he will have committed fraud but he has categorically covered this point. Peggy/chinablue stop lying.
I’m not putting a time frame now, I have a price and will
Sit tight, we have a route to cash flow now in the mean time.
Longfellow I’m sure AA will want to make a decent offer. We would be nuts to offer them that with copper where it is and others looking to get in here and locked out.
Also we don’t have to sell to them if they can’t give us a good deal.
Arcm are in a strong position